en · de · es · fr · pt
analytical-notes.peptides6608.com › News › Background And Research Context — Explained

Background And Research Context — Explained

By Editorial Desk · published 2025-09-11 · last reviewed 2025-10-13 · News

Cardarine comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2025-10-13. Numbers and descriptions here follow the published literature rather than marketing material.

Background and Research Context

PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.

In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.

Identity and Regulatory Status

Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.

Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.

Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.

Cardarine at a glance

PropertyValueNotes
CAS Registry Number317318-70-0Unique identifier for the compound.
Chemical classPPARδ agonistSynthetic ligand for peroxisome proliferator-activated receptor delta.
AppearanceWhite to off-white solidTypical form of research-grade material.
SolubilitySoluble in DMSO and ethanolPoorly soluble in water.
Typical storage-20°CRecommended for long-term storage of stock solutions.

Identity and Pharmacological Classification

PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.

Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.

Related pages on this site

Cardarine Identity and Mechanism

Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.

Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.

Supporting material

=== Shop N Save === Dairy Farm Singapore acquired Shop N Save in 2003, 35 stores from QAF and Belgian retailer, Delhaize. It was a former discount supermarket chain in Singapore, operating 50 stores located across the island in HDB estates and suburban malls. It sells a range of cheap products and fresh food. In 2013, it was merged with Giant.

Henry Slattery (born 22 January 1986) is a former professional Australian rules footballer who played for the Essendon Football Club in the Australian Football League (AFL). Henry Slattery attended Rostrevor College in Adelaide, South Australia. Slattery was recruited by Essendon with selection 46 in the 2004 AFL draft. He had previously played for West Adelaide in the SANFL. He made his debut in 2005 against St Kilda, kicking a goal in what was Matthew Lloyd's 200th AFL game. His first three seasons were limited by hip and knee injuries before he cemented his place in the Essendon starting team, often as a small, lock-down defender or defensive midfielder. At the end of the 2012 AFL season, Slattery decided to leave Essendon in search of greater opportunities at AFL level, after playing in only 2 games for the year, nominating South Australia as his preferred destination. He was not selected in the 2012 AFL draft, but was recruited by the Port Adelaide Magpies in the South Australian National Football League (SANFL). Slattery, along with 33 other Essendon players, was found guilty of using a banned performance-enhancing substance, thymosin beta-4, as part of Essendon's sports supplements program during the 2012 season. He and his team-mates were initially found not guilty in March 2015 by the AFL Anti-Doping Tribunal, but a guilty verdict was returned in January 2016 after an appeal by the World Anti-Doping Agency.

Perfluoroaromatic compounds can be manufactured via the Fowler process, like fluoroalkanes, but the conditions must be adjusted to prevent full fluorination. They can also be made by heating the corresponding perchloroaromatic compound with potassium fluoride at high temperature (typically 500 °C), during which the chlorine atoms are replaced by fluorine atoms. A third route is defluorination of the fluoroalkane; for example, octafluorotoluene can be made from perfluoromethylcyclohexane by heating to 500 °C with a nickel or iron catalyst. Perfluoroaromatic compounds are relatively volatile for their molecular weight, with melting and boiling points similar to the corresponding aromatic compound, as the table below shows. They have high density and are non-flammable. For the most part, they are colorless liquids. Unlike the perfluoralkanes, they tend to be miscible with common solvents.

Samples are dissolved or suspended in a "cocktail" containing a solvent (historically aromatic organics such as xylene or toluene, but more recently less hazardous solvents are used), typically some form of a surfactant, and "fluors" or scintillators which produce the light measured by the detector. Scintillators can be divided into primary and secondary phosphors, differing in their luminescence properties. Beta particles emitted from the isotopic sample transfer energy to the solvent molecules: the π cloud of the aromatic ring absorbs the energy of the emitted particle. The energized solvent molecules typically transfer the captured energy back and forth with other solvent molecules until the energy is finally transferred to a primary scintillator. The primary phosphor will emit photons following absorption of the transferred energy. Because that light emission may be at a wavelength that does not allow efficient detection, many cocktails contain secondary phosphors that absorb the fluorescence energy of the primary phosphor and re-emit at a longer wavelength. Two widely used primary and secondary fluors are 2,5-diphenyloxazole (PPO) with an emission maximum of 380 nm and 1,4-bis-2-(5-phenyloxazolyl)benzene (POPOP) with an emission maximum of 420 nm. The radioactive samples and cocktail are placed in small transparent or translucent (often glass or plastic) vials that are loaded into an instrument known as a liquid scintillation counter. Newer machines may use 96-well plates with individual filters in each well.

Flunarizine, sold under the brand name Sibelium among others, is a drug classified as a calcium antagonist which is used for various indications. It is not available by prescription in the United States or Japan. The drug was discovered at Janssen Pharmaceutica (R14950) in 1968.

Sources: en.wikipedia.org

Notes from published material

=== June === 1 June – Robert Anderson, cricketer (Otago, Central Districts, national team) (born 1948). 4 June Edwin Perry, politician, New Zealand First list MP (2002–2005), Masterton District Councillor (2007–2010) (born 1948). Bruce Stewart, lawyer, Rhodes Scholar (1975), King's Counsel (since 2000) (born 1953). 6 June – Marise Wipani, beauty pageant contestant, actor (Came a Hot Friday, Shortland Street, Soldier Soldier), and television presenter (Lotto) (born 1964). 7 June – David Lean, local politician, Mayor of New Plymouth (1980–1992), Taranaki Regional Councillor (since 1989) (born 1948). 8 June Anthony Reid, historian (Australian National University, UCLA, National University of Singapore) (born 1939). Stu Wilson, rugby union player (Wellington, national team) and television commentator (born 1954). 10 June – Roka Ngarimu-Cameron, tohunga raranga and traditional Māori arts academic (University of Otago) (born 1948). 12 June Maurice Gee, novelist (Under the Mountain, In My Father's Den, Plumb), Arts Foundation of New Zealand Icon (since 2003) (born 1931). Phil Silva, psychologist and paediatrician (University of Otago), founder (1972) and director (1972–1999) of the Dunedin Study (born 1940). Sir Cliff Skeggs, Hall of Fame businessman and local politician, Mayor of Dunedin (1977–1989) (born 1931). 14 June – Lorraine Barry, music manager (Dave Dobbyn, Ice-T, Spice Girls) (born c. 1958). 15 June – Barry Vercoe, computer scientist (Massachusetts Institute of Technology) and composer, inventor of Csound (1985) (born 1937).

== Other == Civic Democratic Party (Czech: Občanská demokratická strana) Civic Democratic Party (Slovakia) (Slovak: Občianska demokratická strana) Odesa International Airport, an airport in Odesa, Ukraine (IATA code ODS) L'Officiel du jeu Scrabble, the reference dictionary for Scrabble in French-speaking countries One Day School, a gifted education program in New Zealand. Operating Deflection Shape, a method used for visualisation of the vibration pattern of a machine Ordbog over det danske Sprog, a dictionary of Danish Overdoses (especially drug overdoses) In Liverpool in England, Old Dock Sill Orbital Dysfunctional Syndrome from the film Pandorum Occupy Dame Street, a protest in Dublin, Ireland in 2011–12

Nuclear medicine is the use of open radionuclides for diagnostic and therapeutic purposes (radionuclide therapy). It also includes the use of other radioactive substances and nuclear physics techniques for functional and localization diagnostics. George de Hevesy (1885-1966) lived as a lodger and in 1923 suspected that his landlady was offering him pudding that he had not eaten the following week. He mixed a small amount of a radioactive isotope into the leftovers. When she served him the pudding a week later, he was able to detect radioactivity in a sample of the casserole. When he showed this to his landlady, she immediately gave him notice. The method he used made him the father of nuclear medicine. It became known as the tracer method, which is still used today in nuclear medicine diagnostics. A small amount of a radioactive substance, its distribution in the organism, and its path through the human body can be tracked externally. This provides information about various metabolic functions of the body. The continuous development of radionuclides has improved radiation protection. For example, the mercury compounds 203chloro-merodrin and 197chloro-merodrin were abandoned in the 1960s as substances were developed that allowed a higher photon yield with less radiation exposure. Beta emitters such as 131I and 90Y are used in radionuclide therapy. In nuclear medicine diagnostics, the beta+ emitters 18F, 11C, 13N, and 15O are used as radioactive markers for tracers in positron emission tomography (PET).

The agent A-234 is also supposedly around five to eight times more potent than VX. The median lethal dose for inhaled A-234 has been estimated as 7 mg/m3 for two minute exposure (minute volume of 15 L, slight activity). The median lethal dose for inhaled A-230, likely the most toxic liquid Novichok, has been estimated as between 1.9 and 3 mg/m3 for two minute exposure. Thus the median lethal dose for inhaled A-234 is 0.2 mg (5000 lethal doses in a gram) and is below 0.1 mg for A-230 (10 000 lethal doses in a gram).

Sources: en.wikipedia.org

Background from the literature

Alcohol powder, powdered alcohol or dry alcohol is a powder that becomes an alcoholic drink when water is added. It is made using micro-encapsulation of alcohol (specifically ethanol). In March 2015 four product labels for specific powdered alcohol products were approved by the United States Alcohol and Tobacco Tax and Trade Bureau (TTB) which opened the doors for legal product sales. However, as of 4 January 2016, the product is not yet available for sale and legalization remains controversial due to public-health and other concerns. Researchers have expressed concern that, should the product go into production, increases in alcohol misuse, alcohol use disorder, and associated physical harm to its consumers could occur above what has been historically associated with liquid alcohol alone.

== Description == The plant is a climber with leaves having soft hairs on the upper surface. The leaves are elongated-oval in shape. It has a small, yellow, umbelliferous inflorescence that is produced throughout the year.

In 2002, the Parliament of India passed an act called the Prevention of Money Laundering Act, 2002. The main objectives of this act are to prevent money-laundering as well as to provide for confiscation of property either derived from or involved in, money-laundering. Section 12 (1) describes the obligations that banks, other financial institutions, and intermediaries have to

Paralytic shellfish poisoning (PSP) is one of the four recognized syndromes of shellfish poisoning, which share some common features and are primarily associated with bivalve mollusks (such as mussels, clams, oysters and scallops). These shellfish are filter feeders and accumulate neurotoxins, chiefly saxitoxin, produced by microscopic algae, such as dinoflagellates, diatoms, and cyanobacteria. Dinoflagellates of the genus Alexandrium are the most numerous and widespread saxitoxin producers and are responsible for PSP blooms in subarctic, temperate, and tropical locations. The majority of toxic blooms have been caused by the morphospecies Alexandrium catenella, Alexandrium tamarense, Gonyaulax catenella and Alexandrium fundyense, which together comprise the A. tamarense species complex. In Asia, PSP is mostly associated with the occurrence of the species Pyrodinium bahamense. Some pufferfish, including the chamaeleon puffer, also contain saxitoxin, making their consumption hazardous.

The pivotal event of Naram-Sin's reign was a widespread revolt against the Akkadian Empire. The empire created by his grandfather, Sargon, first ruler of the Akkadian Empire stretched in the west to Syria in places like Tell Brak and Tell Leilan, to the east in Elam and associated polities in that region, to southern Anatolia in the north, and to the "lower sea" in the south encompassing all the traditional Sumerian powers like Uruk, Ur, and Lagash. All of these political entities had long histories as independent powers and would periodically re-assert their interests throughout the lifetime of the Akkadian Empire.

Sources: en.wikipedia.org

Frequently asked questions

What is cardarine?

Cardarine is a common name for GW501516, a synthetic PPARδ agonist developed for research. It has not been approved as a medication in any country. It is classified as an unapproved drug and a prohibited substance in sport.

Is cardarine a steroid?

No. Cardarine is not an anabolic steroid; it belongs to a different chemical class that targets PPARδ. Steroids act primarily through androgen receptors, while cardarine acts through a nuclear receptor involved in metabolism.

What did animal studies find?

Some rodent studies reported increased endurance and changes in fat metabolism after cardarine exposure. Long-term studies in animals also raised concerns about cancer in certain tissues. Human trial data are limited, so these findings cannot be directly translated to people.

Is cardarine a SARM?

No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.

Network